915095-96-4

Basic information

• Product Name: methyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside
• Synonyms: methyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside
• CAS NO: 915095-96-4
• Molecular Weight: 480.942
• Mol File: 915095-96-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside(915095-96-4)
• EPA Substance Registry System: methyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside(915095-96-4)

Safety Data

• Hazardous Substances Data: 915095-96-4(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 90-80-2 D-Glucono-1,5-lactone 
• 915095-94-2 (3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran 
• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 915095-89-5 (S)-4-bromo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)benzene 

Downstream Products

• 864070-44-0 empagliflozin 
• 1417573-74-0 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucopyranoside 
• 2069942-68-1 methyl-2,4,6-tetra-O-acetyl-1-C-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucopyranoside 
• 915095-99-7 (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-trityl triacetate 

Relevant articles and documents

A SYNTHESIS METHOD OF GLIFLOZIN USING CONTINUOUS PROCESS

The present invention relates to a method for gliflozin synthesis, comprising the steps of: (a) preparing a first product by making a stream comprising an initial reactant and a lactone react with a stream comprising n-Butyllithium; and (b) making the stream comprising the first product react with a stream comprising p-toluenesulfonic acid (PTSA) to produce a second product.COPYRIGHT KIPO 2020

COMPLEX OF SGLT2 INHIBITOR AND PROCESS FOR PREPARATION THEREOF

The present invention relates to a crystalline Form A of complex of Empagliflozin with L-Proline and process for preparation thereof. The present invention further relates to a method of preparing pure crystalline Empagliflozin via formation of the said complex.